Dongjin Nam

Dongjin Nam

Auto-generated profile, based on publicly available information

Dongjin Nam

Department of Internal Medicine, Graduate School, Yonsei University College of Medicine, Seoul 03722, Republic of Korea

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 April 2026 in Science Progress
Verified
Journal Article
Open access
HKHeesuk Kim
Heesuk Kim
BJByung-Hyun Joe
Byung-Hyun Joe
DNDongjin Nam
Dongjin Nam
TYTae Keun Yoo
Tae Keun Yoo
Dyslipidemia comprises interacting disturbances in lipids and lipoproteins that track with metabolic status, vascular biology, and inflammation. Ocular imaging offers scalable, quantifiable phenotypes to interrogate lipid-related pathways and to develop oculomics. We conducted a scoping review to map evidence linking dyslipidemia and lipid-related biomarkers with ocular phenotypes across the ocular surface, lens, macula, retinal microvasculature, and vascular occlusive disease, and to consider implications for AI-based risk modeling. We searched PubMed, Embase, Scopus, and Web of Science, supplemented by reference screening, and charted lipid exposures such as LDL-C, non-HDL-C, apoB/apoA-I, and the triglyceride-glucose index. The biologically grounded patterns were observed in macular disease, where cholesterol- and apolipoprotein-related material within the RPE-Bruch’s membrane complex and drusen-related phenotypes support lipid-handling and innate immune pathways in age-related macular degeneration. Retinal vascular phenotypes showed generally consistent signals compatible with endothelial stress and microvascular remodeling. Epidemiologic associations were apparent in metabolically co-traveling conditions such as meibomian gland dysfunction and diabetic retinopathy, in which triglyceride-rich dyslipidemia and insulin resistance markers were often more informative than LDL-C alone and associations were often non-linear or interaction-dependent. By contrast, findings for glaucoma and cataract were modest and inconsistent, while vascular occlusive phenotypes clustered with broader atherosclerotic risk. Statin associations varied by outcome and were vulnerable to confounding. Predicting individual lipid analytes from retinal images appears limited, whereas integrated ocular signatures may support cardiovascular risk stratification. Future studies should refine phenotype definitions, model non-linearity, account for lipid-lowering therapy, and prospectively validate multimodal oculomics and AI across devices and populations.

31 July 2025 in Cardiovascular Prevention and Pharmacotherapy
Verified
Journal Article
Open access
JCJungkyung Cho
Jungkyung Cho
JSJaewon Seo
Jaewon Seo
JPJunseok Park
Junseok Park
DNDongjin Nam
Dongjin Nam
TPTae Hyun Park
Tae Hyun Park
MJMiso Jang
Miso Jang
Background: Although retinal imaging–based artificial intelligence (AI) tools have recently been introduced for cardiovascular disease (CVD) risk assessment, little is known about the distribution of these AI-derived scores across the full age spectrum or their associations with traditional cardiometabolic risk factors at different ages.Methods: We analyzed data from 138,745 participants who underwent routine health examinations at two health screening centers in Seoul, Korea. The AI-based retinal CVD risk score (Dr.Noon CVD), as well as anthropometric, hemodynamic, and metabolic indices and cardiometabolic disease status, were compared across ages 16 to 96 years. In a subgroup of 13,182 individuals who underwent coronary artery calcium scoring (CACS) by cardiac computed tomography, we evaluated the performance of the Dr.Noon CVD score in detecting CACS using receiver operating characteristic curve analysis.Results: Mean Dr.Noon CVD scores rose steadily with age from 14.2±2.9 (0, and an area under the curve of 0.82 (95% confidence interval, 0.81–0.83) for identifying significant calcification burden, defined as CACS >100.Conclusions: Dr.Noon CVD scores were consistently correlated with age, conventional risk factors, and CACS, suggesting a potential role in broad-based cardiovascular risk stratification and in guiding personalized prevention strategies.

Verified
Journal Article
Open access
PDF file
SJSung Hoon Jung
Sung Hoon Jung
SKSung-Goo Kang
Sung-Goo Kang
SSSang-Wook Song
Sang-Wook Song
SKSe-Hong Kim
Se-Hong Kim
DNDongjin Nam
Dongjin Nam
JRJunseung Rho
Junseung Rho
Background: The deep learning-derived retinal cardiovascular risk index (Reti-CVD) is a deep learning-derived retinal biomarker calculated from non-mydriatic fundus photographs for cardiovascular risk assessment. This study examined whether obesity phenotype, particularly central adiposity, modifies the association between Reti-CVD and coronary artery calcium score (CACS) in asymptomatic adults undergoing routine health screening. Methods: We retrospectively analyzed 237 Korean adults who underwent fundus photography for Reti-CVD assessment and cardiac computed tomography for CACS measurement. Abdominal obesity was defined as waist circumference (WC) ≥ 90 cm in men and ≥85 cm in women, and general obesity as body mass index (BMI) ≥ 25 kg/m2. Multivariable linear regression models with sequential adjustment were used to evaluate the association between Reti-CVD and CACS. Effect modification was assessed using interaction terms for Reti-CVD×WC and Reti-CVD×BMI. Discriminatory performance for coronary calcification, defined as CACS > 0, was evaluated using the area under the receiver operating characteristic curve (AUC). Results: Abdominal obesity was present in 78 participants (32.9%), and general obesity in 102 (43.0%). Participants with CACS > 0 had significantly higher Reti-CVD scores than those with CACS = 0 (0.15 ± 0.09 vs. 0.09 ± 0.05; p < 0.001). Reti-CVD remained positively associated with CACS after adjustment for metabolic and lifestyle factors. In fully adjusted models, WC significantly moderated this association (interaction p = 0.0288), whereas BMI did not (interaction p = 0.5381). Overall discrimination for CACS > 0 was moderate (AUC = 0.735) and numerically higher in participants with abdominal obesity than in those with normal WC (0.787 vs. 0.695). Conclusions: Reti-CVD is independently associated with coronary calcification, and WC-based central adiposity modifies this relationship. Incorporating obesity phenotype may improve personalized interpretation of retinal biomarker-based cardiovascular risk assessment.

1 January 2026 in Clinical Hypertension
Verified
Journal Article
Open access
PDF file
DNDongjin Nam
Dongjin Nam
JSJaewon Seo
Jaewon Seo
Sahil ThakurSahil Thakur
Sahil Thakur
SNSimon Nusinovici
Simon Nusinovici
TYTae Keun Yoo
Tae Keun Yoo
SPSungha Park
Sungha Park
Nam D, et al. Clin Hypertens. 2026 ;32(1):e38. https://doi.org/10.5646/ch.2026.32.e38

3 August 2026 in American Journal of Preventive Cardiology
Verified
Journal Article
Open access
Sahil ThakurSahil Thakur
Sahil Thakur
JSJaewon Seo
Jaewon Seo
ZDZahra Darmani
Zahra Darmani
DNDongjin Nam
Dongjin Nam
HKHusain Khaki
Husain Khaki
TRTyler Hyungtaek Rim
Tyler Hyungtaek Rim

3 November 2026 in Journal of Clinical Medicine
Verified
Journal Article
Open access
PDF file
JYJung Soo Yoon
Jung Soo Yoon
JKJiyeong Kim
Jiyeong Kim
LLLei Liu
Lei Liu
DNDongjin Nam
Dongjin Nam
SHSunjin Hwang
Sunjin Hwang
Background/Objectives: To determine whether prior cardiovascular disease (CVD) independently predicts diabetic retinopathy (DR) in adults with newly diagnosed type 2 diabetes mellitus (T2DM). Methods: A retrospective nationwide population-based cohort study was conducted using the Korean National Health Insurance Service database. Adults aged ≥40 years with newly diagnosed T2DM were identified after a 7-year washout period. After 1:1 propensity score matching on age and sex, the analytical cohort comprised 38,812 patients per group. Results: After full covariate adjustment, prior CVD was not independently associated with any DR (HR, 1.01; 95% confidence interval [CI], 0.99–1.04; p = 0.262), NPDR (HR, 1.01; 95% CI, 0.98–1.03; p = 0.605), PDR (HR, 1.01; 95% CI, 0.95–1.06; p = 0.835), or VTDR (HR, 1.00; 95% CI, 0.95–1.06; p = 0.893). Fine–Gray models, accounting for higher all-cause mortality in the prior CVD group after matching (25.2% vs. 22.1%), revealed slightly lower sHR for any DR (sHR, 0.97; 95% CI, 0.95–0.99; p = 0.014) and NPDR (sHR, 0.97; 95% CI, 0.94–0.99; p = 0.005). Conclusions: Prior CVD was not independently associated with incident DR. The lower sHRs may partly reflect competing mortality and should not be interpreted as DR protection. Overall, CVD history was not a criterion for intensified DR screening.